The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Effect of Partial Ileal Bypass Surgery on Mortality and Morbidity from Coronary Heart Disease in Patients with Hypercholesterolemia: Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)
Open accessAbstract
BACKGROUND AND METHODS: The Program on the Surgical Control of the Hyperlipidemias (POSCH), a randomized clinical trial, was designed to test whether cholesterol lowering induced by the partial ileal bypass operation would favorably affect overall mortality or mortality due to coronary heart disease. The study population consisted of 838 patients (417 in the control group and 421 in the surgery group), both men (90.7 percent) and women, with an average age of 51 years, who had survived a first myocardial infarction. The mean follow-up period was 9.7 years. RESULTS: When compared with the control group at five years, the surgery group had a total plasma cholesterol level 23.3 percent lower (4.71 +/- 0.91 vs. 6.14 +/- 0.89 mmol per liter [mean +/- SD]; P less than 0.0001), a low-density lipoprotein cholesterol level 37.7 percent lower (2.68 +/- 0.78 vs. 4.30 +/- 0.89 mmol per liter; P less than 0.0001), and a high-density lipoprotein cholesterol level 4.3 percent higher (1.08 +/- 0.26 vs. 1.04 +/- 0.25 mmol per liter; P = 0.02). Overall mortality and mortality due to coronary heart disease were reduced, but not significantly so (deaths overall [control vs. surgery], 62 vs. 49, P = 0.164; deaths due to coronary disease, 44 vs. 32, P = 0.113). The overall mortality in the surgery subgroup with an ejection fraction greater than or equal to 50 percent was 36 percent lower (control vs. surgery, 39 vs. 24; P = 0.021). The value for two end points combined--death due to coronary heart disease and confirmed nonfatal myocardial infarction--was 35 percent lower in the surgery group (125 vs. 82 events; P less than 0.001). During follow-up, 137 control-group and 52 surgery-group patients underwent coronary-artery bypass grafting (P less than 0.0001). A comparison of base-line coronary arteriograms with those obtained at 3, 5, 7, and 10 years consistently showed less disease progression in the surgery group (P less than 0.001). The most common side effect of partial ileal bypass was diarrhea; others included occasional kidney stones, gallstones, and intestinal obstruction. CONCLUSIONS: Partial ileal bypass produces sustained improvement in the blood lipid patterns of patients who have had a myocardial infarction and reduces their subsequent morbidity due to coronary heart disease. The role of this procedure in the management of hypercholesterolemia remains to be determined. These results provide strong evidence supporting the beneficial effects of lipid modification in the reduction of atherosclerosis progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Specifically, each 1-mmol/L reduction in LDL-C was associated with an RR of 0.75 (95% CI, 0.66-0.86;P = .002)in major vascular events”
From Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis (2016) · cites this paper as [51]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Practical Nonparametric Statistics
Groggel, D. J., & Conover, W. J. (2000) · Technometrics · doi:10.2307/1271101 · Cited by 11,076
Immunochemical quantitation of antigens by single radial immunodiffusion
Mancini, G., Carbonara, A. O., & Heremans, J. F. (1965) · Immunochemistry · doi:10.1016/0019-2791(65)90004-2 · Cited by 9,091
Hubert, H. B., Feinleib, M., McNamara, P. M., & Castelli, W. P. (1983) · Circulation · doi:10.1161/01.cir.67.5.968 · Cited by 4,241
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
A Generalized Wilcoxon Test for Comparing Arbitrarily Singly-Censored Samples
Gehan, E. A. (1965) · Biometrika · doi:10.1093/biomet/52.1-2.203 · Cited by 3,407
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.256.20.2835 · Cited by 2,512
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1976) · British Journal of Cancer · doi:10.1038/bjc.1976.220 · Cited by 2,294
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study.
Kannel, W., Castelli, W., Gordon, T., & McNamara, P. M. (2020) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-1-1 · Cited by 2,160
Research works printed but not linked: 29
- 10.1001/jama.256.20.2823 · DOI · Paper page
- Leren, 1966, Acta Med Scand Suppl, 466, 1
- 1968, Lancet, 2, 693
- Frantz, 1975, Circulation, 52, II-4
- 10.1001/jama.231.4.360 · DOI
- 10.1001/jama.251.3.351 · DOI · Paper page
- 10.1001/jama.257.23.3233 · DOI
- Buchwald H. Intestinal bypass for hypercholesterolemia. In: Nyhus LM, Baker RJ, eds. Mastery of surgery. Vol. 3. Boston: Little, Brown, 1984:901–7.
- Buchwald H, Campos CT. Partial ileal bypass for control of hyperlipidemia and atherosclerosis. In: Sabiston DC Jr, Spencer FC, eds. Surgery of the chest. 5th ed. Philadelphia: W.B. Saunders, 1990:1799–819.
- Schouten, 1986, Artery, 13, 240
- 1959, Stat Bull Metrop Life Insur Co, 40, 1
- Bruce, 1971, Ann Clin Res, 3, 323
- National Heart and Lung Institute, Lipid Research Clinics Program. Manual of laboratory operations. Vol. 1. Bethesda, Md.: National Institutes of Health, 1974. (DHEW publication no. (NIH) 75–628.)
- 1970, Bull World Health Organ, 43, 891
- Mantel, 1966, Cancer Chemother Rep, 50, 163
- Matts, Controlled Clin Trials
- Campos, 1987, Surgery, 102, 424
- Campos, 1988, Curr Surg, 45, 380
- Campos, 1988, Surg Forum, 39, 193
- Addison, 1851, Guys Hosp Rep, 2, 267
- Ignatovski, 1908, Izviest Imp Voyenno-med Akad S Petersb, 16, 154
- Anitschkow, 1913, Centralbl Allg Pathol Pathol Anat, 24, 1
- Wacker, 1913, Münchener Med Wochenschr, 60, 2097
- European Coronary Surgery Study Group, 1982, Lancet, 2, 1173
- Buchwald, 1965, Surgery, 58, 22
- Scott, 1967, Surg Gynecol Obstet, 125, 3
- Buchwald, 1963, Circulation, 28, II-649
- Moore, 1969, Surgery, 65, 98
- Buchwald, Ann Surg
Cited by
Sorted by citations
Items 601–700 of 1,000
Auyang, E. D., Murayama, K. M., & Nagle, A. P. (2008) · Obesity Surgery · doi:10.1007/s11695-008-9682-9 · Cited by 7
The Effect of Gastric Bypass on Cholesterol, HDL, and the Risk of Coronary Heart Disease
Jones, K. B. (1992) · Obesity Surgery · doi:10.1381/096089292765560600 · Cited by 7
PCSK9: the Critical Role of Familial Hypercholesterolemia from Discovery to Benefit for all
Stein, E. A. (2016) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-016-6690-1 · Cited by 7
Familial Hepatocellular Cholestasis
Suchy, F. J., & Shneider, B. L. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511547409.016 · Cited by 7
Jost, S., Deckers, J. W., Nikutta, P., Reiber, J. H. C., Rafflenbeul, W., Wiese, B., Hecker, H., & Lichtlen, P. R. (1995) · American Heart Journal · doi:10.1016/0002-8703(95)90348-8 · Cited by 6
Treating to target with statins
Barter, P. J. (2000) · Atherosclerosis Supplements · doi:10.1016/s0021-9150(00)00564-5 · Cited by 7
Sakai, A., Hirayama, A., Adachi, T., Nanto, S., Hori, M., Inoue, M., Kamada, T., & Kodama, K. (2005) · Heart and Vessels · doi:10.1007/bf01746206 · Cited by 2
DeFranco, A. C. (2002) · European Heart Journal Supplements · doi:10.1016/s1520-765x(02)90027-1 · Cited by 7
Porkka, K., & Viikari, J. S. A. (1994) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1994.tb01273.x · Cited by 7
Relationship of human pancreatic cholesterol esterase gene structure with lipid phenotypes
Aleman-Gomez, J. A., Colwell, N. S., Vyas, K., Borecki, I. B., Schonfeld, G., Lange, L. G., & Kumar, V. B. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00196-4 · Cited by 7
Demetriou, K., H’Maltezou, E., & Pierides, A. (2001) · Blood Purification · doi:10.1159/000046959 · Cited by 7
Dyslipoproteinemia and Peripheral Arterial Occlusive Disease
Kröger, K. (2004) · Angiology · doi:10.1177/000331970405500204 · Cited by 7
Aspry, K. E., Holcroft, J. W., & Amsterdam, E. A. (1995) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(18)30440-9 · Cited by 7
Drug therapy of hyperlipidemia
Prihoda, J. S., & Illingworth, D. R. (1992) · Current Problems in Cardiology · doi:10.1016/0146-2806(92)90004-8 · Cited by 7
The Future of Bariatric Surgery
Cowan, G. S. M. (1992) · Obesity Surgery · doi:10.1381/096089292765560376 · Cited by 7
Pearson, T. A., & Swan, H. J. C. (1996) · Cardiology Clinics · doi:10.1016/s0733-8651(05)70265-4 · Cited by 7
Cohen, J. D. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00655-8 · Cited by 7
Wilensky, R. L. (1998) · Developments in cardiovascular medicine · doi:10.1007/978-1-4615-5715-9_4 · Cited by 7
Familial Hypercholesterolemia: From Clinical Suspicion to Novel Treatments
Mirzai, S., Chevli, P. A., Rikhi, R. R., & Shapiro, M. D. (2023) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2411311 · Cited by 8
Bariatric Surgery: A Systematic Review and
Sjöström, C. D. (2008) · Cited by 6
Atherosclerosis progression/regression: lipoprotein and vessel wall determinants
Krarnsch, D. M. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)90070-5 · Cited by 6
Treatment of essential hypertension and non-insulin dependent diabetes mellitus with vitamin C
Nimbkar, N. V., & Lateef, F. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.09.029 · Cited by 6
Does it matter whether or not a lipid-lowering agent inhibits Rho kinase?
Liao, J. K. (2007) · Current Atherosclerosis Reports · doi:10.1007/s11883-007-0049-9 · Cited by 6
Point: Statins, plant sterol absorption, and increased coronary risk
Goldstein, M. R., Mascitelli, L., & Pezzetta, F. (2008) · Journal of clinical lipidology · doi:10.1016/j.jacl.2008.06.005 · Cited by 6
van de Wetering, G., Rikkert, M. G. M. O., van der Wilt, G. J., & Adang, E. (2014) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462314000762 · Cited by 6
DIFFERENTIAL EFFECTS OF LIPID-LOWERING THERAPIES ON STROKE PREVENTION
Corvol, J., Bouzamondo, A., Sirol, M., Hulot, J., Sanchez, P., & Lechat, P. (2003) · Evidence-Based Eye Care · doi:10.1097/00132578-200307000-00014 · Cited by 10
What every doctor wants to know about cholesterol: answers to some difficult questions
Durrington, P. N. (1992) · Postgraduate Medical Journal · doi:10.1136/pgmj.68.805.867 · Cited by 6
Intensive statin therapy in acute coronary syndromes
Liew, T. V., & Ray, K. K. (2008) · Current Atherosclerosis Reports · doi:10.1007/s11883-008-0023-1 · Cited by 6
Issa, J. S., Garrido, A., Giannini, S. D., Forti, N. A., Diament, J., & PINOTTI, H. W. (2000) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2000000700005 · Cited by 6
Dyslipidemias and the secondary prevention of coronary heart disease
Rosenson, R. S., Frauenheim, W. A., & Tangney, C. (1994) · Disease-a-Month · doi:10.1016/0011-5029(94)90027-2 · Cited by 6
Brown, W. V. (2001) · Current Controlled Trials in Cardiovascular Medicine · doi:10.1186/cvm-2-1-012 · Cited by 6
Lipid-lowering therapies in development
Wierzbicki, A. S. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.11.1405 · Cited by 6
Baruch, L., Gupta, B. P., Lieberman-Blum, S. S., Agarwal, S., & Eng, C. (2008) · PubMed · Cited by 6
Schiel, R., Bambauer, R., & Müller, U. (1995) · International Journal of Artificial Organs · doi:10.1177/039139889501801207 · Cited by 5
Alazmi, W. M., Fogel, E. L., Watkins, J. L., McHenry, L., Sherman, S., & Lehman, G. A. (2007) · Canadian Journal of Gastroenterology · doi:10.1155/2007/502931 · Cited by 6
Wess, G., Enhsen, A., & Kramer, W. (1995) · Nachrichten aus Chemie Technik und Laboratorium · doi:10.1002/nadc.19950431008 · Cited by 6
Hall, L. K. (1998) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-199801000-00001 · Cited by 6
Pharmacological control of hypertriglyceridemia
Franceschini, G., & Paoletti, R. (1993) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00880152 · Cited by 6
Cholesterol and lipoproteins: Beyond atherogenesis
Kuhn, F. E., Mohler, E. R., & Rackley, C. E. (1992) · Clinical Cardiology · doi:10.1002/clc.4960151207 · Cited by 6
CHOLESTEROL AND CORONARY HEART DISEASE IN WOMEN
Lewis, S. J. (1998) · Cardiology Clinics · doi:10.1016/s0733-8651(05)70379-9 · Cited by 6
Cholesterol lowering does have a role in secondary prevention.
Wood, D. A. (1995) · Heart · doi:10.1136/hrt.73.1.4 · Cited by 6
Efficacy of interventions designed to inhibit the progression of coronary atherosclerosis
Macka, W. J., & Hodis, H. N. (1996) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(96)80037-4 · Cited by 6
Rader, D. J. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000154483.28595.a3 · Cited by 6
Banks, T., & Ali, N. (2001) · PubMed Central · Cited by 6
The value of lipid lowering in patients with coronary heart disease
Karnik, R. (2001) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 6
Shikora, S. A., Edgerton, C. A., Harris, D. A., & Buchwald, H. (2021) · Current Problems in Surgery · doi:10.1016/j.cpsurg.2021.101059 · Cited by 6
Self-citationCharland, S. L., & Stanek, E. J. (2013) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1368 · Cited by 5
Taşkın, H. E., Kocael, A., Kocael, A., Zengin, K., Al, M., Sözer, V., Buchwald, J. N., McGlennon, T. W., & Uzun, H. (2022) · Surgical Endoscopy · doi:10.1007/s00464-021-08989-8 · Cited by 5
Assessing and Reporting Adverse Events
Friedman, L. M., Furberg, C. D., & DeMets, D. L. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1586-3_12 · Cited by 5
Real-time survival prediction in emergency situations with unbalanced cardiac patient data
Reychav, I., Zhu, L., McHaney, R., Zhang, D., Shacham, Y., & Arbel, Y. (2019) · Health and Technology · doi:10.1007/s12553-019-00307-6 · Cited by 5
Hyun, M. H., Lee, Y.-C., Choi, B. G., Na, J. O., Choi, C. U., Kim, J. W., Kim, E. J., Rha, S., Park, C. G., Lee, E. M., et al. (2019) · Cardiovascular Therapeutics · doi:10.1155/2019/3824823 · Cited by 6
Long-term effects of bariatric surgery on cardiovascular risk factors in Singapore
Panday, V., Shabbir, A., Kuntjoro, I., Khoo, E., So, J. B. Y., & Poh, K. K. (2020) · Singapore Medical Journal · doi:10.11622/smedj.2020047 · Cited by 5
Hirsch, A. T., Kalsi, H., & Rooke, T. W. (2007) · Springer eBooks · doi:10.1007/978-1-84628-715-2_81 · Cited by 5
Matsuda, Y., Kramer, J. R., & Matsuda, M. (1995) · Clinical Cardiology · doi:10.1002/clc.4960180710 · Cited by 5
Relation of angiographic and ultrasound assessment of plaque progression to clinical outcomes.
Weintraub, W. S. (1998) · American Journal of Cardiology · doi:10.1016/s0002-9149(98)00269-0 · Cited by 6
Surgery, drugs, lifestyle and hyperlipidemia
Dalessandri, K. M., & Organ, C. H. (1995) · The American Journal of Surgery · doi:10.1016/s0002-9610(99)80179-2 · Cited by 4
Prevention of Heart Disease: Is LDL Reduction the Outcome of Choice? No, There Is More
Shepherd, J., & Park, J.-S. (1998) · Value in Health · doi:10.1046/j.1524-4733.1998.120120.x · Cited by 5
Brachial Artery Flow Pattern and Clinical Backgrounds in Patients with Angina Pectoris
Sugawara, H., Kubota, I., Tomoike, H., & Kubota, I. (1998) · Angiology · doi:10.1177/000331979804900103 · Cited by 5
Reducing cholesterol and atherosclerosis
Hornung, R. S. (2002) · QJM · doi:10.1093/qjmed/95.6.339 · Cited by 5
The coronary artery disease Paradox
Black, H. R. (1996) · American Journal of Hypertension · doi:10.1016/0895-7061(95)00402-5 · Cited by 5
Hypertension and coronary artery disease in non-insulin dependent diabetes--cause and effect?
Yudkin, J. S. (1992) · Journal of the American Society of Nephrology · doi:10.1681/asn.v34s126 · Cited by 5
Gallup, E., & Dujovne, C. A. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.3.561 · Cited by 5
Bjorck, L. M., Welin, C., & Rosengren, A. (2007) · PubMed Central · Cited by 5
The Influence of Angiographic Endpoints on the Outcome of Lipid Intervention Studies
Jukema, J. W., Boven, A. J. V., Zwinderman, A. H., Bal, E. T., Reiber, J. H. C., & Bruschke, A. V. G. (1996) · Angiology · doi:10.1177/000331979604700701 · Cited by 5
Acute Coronary Syndromes: Molecular Basis for Cardiac Risk Factors
Karas, R. H. (1997) · Journal of Thrombosis and Thrombolysis · doi:10.1023/a:1008862026972 · Cited by 4
Non-pharmacological lowering of low-density lipoprotein by apheresis and surgical techniques
Lees, R. S., Cashin-Hemphill, L., & Lees, A. M. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199912000-00012 · Cited by 5
A Lipid Hypothesis: Prediction, Observation and the Triglyceride/HDL Gap
Deslypere, J.-P., & Jackson, G. (1998) · Current Medical Research and Opinion · doi:10.1185/03007999809113345 · Cited by 5
Arntz, H. R., Wunderlich, W., Schnitzer, L., Stern, R., Fischer, F., Agrawal, R., Linderer, T., & Schultheiß, H. (1999) · Zeitschrift für Kardiologie · doi:10.1007/s003920050329 · Cited by 5
Efficacy of drug intervention for lipids in the prevention of coronary artery disease
Howes, L. G., & Simons, L. A. (1994) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1994.tb04445.x · Cited by 5
Selective neointimal gene transfer in an avian model of vascular injury
Wang, R., Xu, M. F., Marcel, R., Bouliane, G., & Fisher, D. Z. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00131-8 · Cited by 5
Partial ileal resection for hypercholesterolaemia in patients undergoing surgery for obesity
Dachtler, J., Johnston, D., Halstead, J. C., & King, R. F. G. J. (1999) · British journal of surgery · doi:10.1046/j.1365-2168.1999.01251.x · Cited by 5
Commentary: Epidemiology, Comparative Effectiveness Research, and the National Institutes of Health
Lauer, M. S., & Hodes, R. J. (2011) · Epidemiology · doi:10.1097/ede.0b013e3182262ac6 · Cited by 5
Cholesterol lowering and emotional distress: Current status and future directions.
Schwartz, S., & Ketterer, M. (1997) · American Psychological Association eBooks · doi:10.1037/10259-006 · Cited by 5
Goldberg, R. B. (2009) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmsott.s3866 · Cited by 5
Fukuda, S., Shimada, K., Fujita, M., Yoshiyama, M., Yoshikawa, J., Kohro, T., Hayashi, D., Yamazaki, T., & Nagai, R. (2013) · Journal of Cardiology · doi:10.1016/j.jjcc.2013.02.006 · Cited by 4
LDL Lowering: Evidence for a Plaque Non-Progression Threshold
Feeman, W. (2016) · International Journal of Cardiovascular Research · doi:10.4172/2324-8602.1000145 · Cited by 3
Obesity 2021: Current Clinical Management of a Chronic, Serious Disease
Kushner (2021) · The Journal of Family Practice · doi:10.12788/jfp.0221 · Cited by 6
Screening for Autoantibodies in Type 1 Diabetes: A Call to Action
Петерс (2021) · The Journal of Family Practice · doi:10.12788/jfp.0223 · Cited by 7
Santos, R. D., Lorenzatti, A. J., Barros, C. F., & Escobar, E. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.02.006 · Cited by 4
The Anatomy of a Clinical Trial
Shepherd, J., & Gaw, A. (2002) · Medical Principles and Practice · doi:10.1159/000066408 · Cited by 159
Using inflammatory biomarkers to guide lipid therapy
Everett, B. M., & Ridker, P. M. (2008) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-008-0007-2 · Cited by 4
Cholesterol reduction and death from noncoronary causes: evidence from randomised controlled trials*
MacMahonf, S. (1994) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1994.tb04447.x · Cited by 5
Intensive statin therapy for treating acute coronary syndromes
Ray, K. K., & Cannon, C. P. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.10.1151 · Cited by 4
Double-blind comparative clinical trial of Abana and Simvastatin in Hyperlipidaemia
Kulkarni, K. S. (2002) · Cited by 4
[Statins in cardiovascular disease. Role of Rho/Rho kinase inhibition and of Akt activation ].
Cosentino, F. (2003) · PubMed · Cited by 4
Panach, K., Garg, A., & Ahmad, Z. (2017) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.117.001767 · Cited by 4
Buchwald, H. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-0089-1.50010-8 · Cited by 4
Self-citationRosenman, R. H. (1993) · Integrative Psychological and Behavioral Science · doi:10.1007/bf02691202 · Cited by 4
Metabolic/Bariatric Surgery Therapy for the Metabolic Syndrome
Buchwald, H. (2011) · Wiley eBooks · doi:10.1002/9781444347319.ch19 · Cited by 4
Self-citationHemphill, L. (2014) · Journal of clinical lipidology · doi:10.1016/j.jacl.2014.09.010 · Cited by 4
Lessons learned from angiographic coronary atherosclerosis trials
Jukema, J. W., Bruschke, A. V. G., & Reiber, J. H. C. (1996) · Developments in cardiovascular medicine · doi:10.1007/978-94-009-0291-6_9 · Cited by 4
Kuller, L. H. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90160-0 · Cited by 4
Randomized Trials to Assess the Long-term Effects of Therapies on Angiographic End Points
Yusuf, S., & Garg, R. (1991) · CHEST Journal · doi:10.1378/chest.99.5.1243 · Cited by 4
What If Americans Ate Less Fat?
Ornish, D. M. (1992) · JAMA · doi:10.1001/jama.267.3.362b · Cited by 5
Nasso, G., Vignaroli, W., Amodeo, V., Bartolomucci, F., Larosa, C., Contegiacomo, G., Demola, M. A., Girasoli, C., Valenzano, A., Fiore, F., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13102987 · Cited by 4
Buchwald, H. (2024) · Annals of Surgery · doi:10.1097/sla.0000000000006588 · Cited by 3
Self-citationHochholzer, W., & Giugliano, R. P. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0290-8 · Cited by 3
History of Metabolic/Bariatric Surgery and Evolution of Evidence
Buchwald, H. (2019) · Springer eBooks · doi:10.1007/978-3-030-25173-4_24 · Cited by 3
Self-citationLipid Risk Factors and the Regression of Atherosclerosis
Gotto, A. M. (1995) · Medical science symposia series · doi:10.1007/978-94-011-0039-7_1 · Cited by 3
Cardiac Risk Factor Improvement Following Bariatric Surgery
Kitamura, R. K., Morton, J. M., & Eisenberg, D. (2019) · Springer eBooks · doi:10.1007/978-3-030-27021-6_46 · Cited by 3
Metadata
- Authors
- Buchwald, H., Varco, R. L., Matts, J. P., Long, J. M., Fitch, L. L., Campbell, G. S., Pearce, M. B., Yellin, A. E., Edmiston, W. A., Smink, R. D., Sawin, H. S., Campos, C. T., Hansen, B. J., Tuna, N., Karnegis, J. N., Sanmarco, M. E., Amplatz, K., Castaneda-Zuniga, W. R., Hunter, D. W., Bissett, J. K., Weber, F. J., Stevenson, J. W., Leon, A. S., & Chalmers, T. C.
- Affiliations
- University of Minnesota (US)
- University of Southern California (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1990-10-04
- Volume
- 323
- Issue
- 14
- Pages
- 946-955
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2331959986
- Cited by
- 1,001
- References
- 58
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 3 · 2023: 9 · 2022: 5 · 2021: 20 · 2020: 11 · 2019: 16 · 2018: 10 · 2017: 11 · 2016: 22 · 2015: 15 · 2014: 17 · 2013: 12 · 2012: 17
- FWCI
- 84.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Surgery › Cardiac and Coronary Surgery Techniques
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- partial ileal bypass, hypercholesterolemia, coronary artery disease, mortality, myocardial infarction, cholesterol lowering, LDL cholesterol, HDL cholesterol, first myocardial infarction, coronary artery bypass grafting, ejection fraction, long-term outcomes, nonfatal myocardial infarction
- MeSH terms
- Adult, Coronary Disease, Electrocardiography, Female, Follow-Up Studies, Humans, Hypercholesterolemia, Hyperlipidemias, Jejunoileal Bypass, Lipids, Male, Middle Aged, Ultrasonography, Multicenter Studies as Topic, Randomized Controlled Trials as Topic, Coronary Angiography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review